Home
About
Services
Partners
Client Portfolio
News
Contact
Coty appoints Chairman Peter Harf as CEO
June 1, 2020
Factbox: What’s new with the Fed’s 2020 bank stress tests?
June 1, 2020
0
Gilead trades that made millions on COVID-19 drug news raise eyebrows
Published by
Muller&Green
at
June 1, 2020
Categories
RSS
Tags
Well-timed trades in Gilead Sciences Inc’s options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw regulatory scrutiny, experts said.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more